All In Biotech

Drug Trial Radar · NCT07917039

SYH2072 Tablets in Participants With Primary Aldosteronism

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2072 Tablets in Chinese Participants With Primary Aldosteronism

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Nov 13, 2026

Primary completion

Feb 1, 2028

Study completion Jun 4, 2028

Sponsor

Sponsor type
Industry
First posted
Nov 4, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, placebo-controlled Phase II study designed to explore the efficacy and safety of SYH2072 tablets in Chinese participants with primary aldosteronism (PA) .

Conditions

  • Primary Aldosteronism

Interventions

  • SYH2072 tabletsDrug

    SYH2072 tablets administered orally, once daily (QD)

  • PlaceboDrug

    Placebo administered orally, once daily (QD).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in seated Systolic Blood Pressure (SBP) at Week 8Time frame: week 8

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.